Innoviva (INVA) Misses Q2 EPS by 79c

Innoviva (NASDAQ: INVA) reported Q2 EPS of ($0.55), $0.79 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $76.28 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• TechCreate Group faces NYSE American delisting proceedings